Two Sigma Securities LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 256.1% during the first quarter, Holdings Channel reports. The firm owned 17,915 shares of the healthcare conglomerate’s stock after buying an additional 12,884 shares during the period. UnitedHealth Group makes up 0.6% of Two Sigma Securities LLC’s investment portfolio, making the stock its 21st largest position. Two Sigma Securities LLC’s holdings in UnitedHealth Group were worth $2,938,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. Quadrant Capital Group LLC increased its stake in shares of UnitedHealth Group by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 4,244 shares of the healthcare conglomerate’s stock valued at $684,000 after buying an additional 180 shares during the period. Gulf International Bank UK Ltd increased its stake in shares of UnitedHealth Group by 2.9% in the first quarter. Gulf International Bank UK Ltd now owns 300,307 shares of the healthcare conglomerate’s stock valued at $49,253,000 after buying an additional 8,593 shares during the period. Raymond James Trust N.A. increased its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Raymond James Trust N.A. now owns 55,809 shares of the healthcare conglomerate’s stock valued at $9,153,000 after buying an additional 456 shares during the period. Osborn Williams & Donohoe LLC increased its stake in shares of UnitedHealth Group by 31.7% in the first quarter. Osborn Williams & Donohoe LLC now owns 12,796 shares of the healthcare conglomerate’s stock valued at $2,099,000 after buying an additional 3,080 shares during the period. Finally, Paradigm Financial Advisors LLC increased its stake in shares of UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the period. 86.37% of the stock is currently owned by institutional investors.

UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.23% during trading on Friday, reaching $193.02. The company had a trading volume of 2,210,720 shares. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04. The company’s 50-day moving average is $189.36 and its 200 day moving average is $174.75. The firm has a market capitalization of $186.62 billion, a price-to-earnings ratio of 23.19 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.96 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-position-increased-by-two-sigma-securities-llc/1479136.html.

A number of analysts have issued reports on the company. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective on the stock in a research note on Tuesday, August 1st. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 price objective (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 price objective (up previously from $190.00) on shares of UnitedHealth Group in a research note on Saturday, July 22nd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $202.20.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.